These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32911899)

  • 21. What will it take to cure hepatitis B?
    Jeng WJ; Lok ASF
    Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
    Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New antivirals for the treatment of chronic hepatitis B.
    Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
    Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus.
    Kim SW; Yoon JS; Lee M; Cho Y
    Clin Mol Hepatol; 2022 Jan; 28(1):17-30. PubMed ID: 34281294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731.
    Huang Q; Cai D; Yan R; Li L; Zong Y; Guo L; Mercier A; Zhou Y; Tang A; Henne K; Colonno R
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent Advances in Hepatitis B Virus Antivirals].
    Liu Q; Yao C; Guo X; Hu K
    Bing Du Xue Bao; 2016 Sep; 32(5):650-8. PubMed ID: 30004193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA.
    Kumar R; Pérez-Del-Pulgar S; Testoni B; Lebossé F; Zoulim F
    Liver Int; 2016 Jan; 36 Suppl 1():72-7. PubMed ID: 26725901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug Discovery Study Aimed at a Functional Cure for HBV.
    Watanabe T; Hayashi S; Tanaka Y
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs in the Pipeline for HBV.
    Lopatin U
    Clin Liver Dis; 2019 Aug; 23(3):535-555. PubMed ID: 31266626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rational selection of virologic and immunological biomarkers and therapeutic endpoints in the clinical trials of new drugs treating chronic hepatitis B].
    Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association
    Zhonghua Gan Zang Bing Za Zhi; 2022 Apr; 30(4):429-438. PubMed ID: 35545570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
    World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Control of replication of hepatitis B and C virus improves patient and graft survival in kidney transplantation.
    Fontaine H; Alric L; Labreuche J; Legendre B; Louvet A; Antoine C; Legendre CM; Hazzan M; Kamar N; Dharancy S; Pol S; Duhamel A; Mathurin P
    J Hepatol; 2019 May; 70(5):831-838. PubMed ID: 30879789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
    Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward a new era of hepatitis B virus therapeutics: The pursuit of a functional cure.
    Tsounis EP; Tourkochristou E; Mouzaki A; Triantos C
    World J Gastroenterol; 2021 Jun; 27(21):2727-2757. PubMed ID: 34135551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?
    Gao Y; Li Y; Meng Q; Zhang Z; Zhao P; Shang Q; Li Y; Su M; Li T; Liu X; Zhuang H
    J Clin Microbiol; 2017 Oct; 55(10):2972-2982. PubMed ID: 28747369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Getting to HBV cure: The promising paths forward.
    Fung S; Choi HSJ; Gehring A; Janssen HLA
    Hepatology; 2022 Jul; 76(1):233-250. PubMed ID: 34990029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients.
    Wang L; Cao X; Wang Z; Gao Y; Deng J; Liu X; Zhuang H
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moving Fast Toward Hepatitis B Virus Elimination.
    Bassit L; Ono SK; Schinazi RF
    Adv Exp Med Biol; 2021; 1322():115-138. PubMed ID: 34258739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection.
    Chen D; Tan X; Chen W; Liu Y; Li C; Wu J; Zheng J; Shen HC; Zhang M; Wu W; Wang L; Xiong J; Dai J; Sun K; Zhang JD; Xiang K; Li B; Ni X; Zhu Q; Gao L; Wang L; Feng S
    J Med Chem; 2022 Aug; 65(16):10938-10955. PubMed ID: 35973101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.